PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2− breast cancer

  1. Terán, E.
  2. Lozano, R.
  3. Rodríguez, C.A.
  4. Abad, M.
  5. Figuero, L.
  6. Muñoz, J.A.
  7. Cigarral, B.
  8. Rodrígues, A.
  9. Sancho, M.
  10. Gómez, M.A.
  11. Morchón, D.
  12. Montero, J.C.
  13. Sayagués, J.M.
  14. Ludeña, M.D.
  15. Fonseca, E.
Journal:
Cancer Medicine

ISSN: 2045-7634

Year of publication: 2024

Volume: 13

Issue: 17

Type: Article

DOI: 10.1002/CAM4.70101 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus